أحدث منشورات MOHAMMED SHAMEEM MUNDOTTIL على لينكدإن

Saudi Pharma 2025: The End of the Riyadh-Centric Era? According to recent market intelligence and projections aligned with IQVIA insights, the Saudi pharmaceutical landscape is entering a multi-regional growth phase moving beyond its historical reliance on the Central Region. This shift is closely aligned with the…

Pharmaceutical Policies in Saudi Arabia 🇸🇦 | Strategic Perspective Saudi Arabia’s pharmaceutical landscape is undergoing a structural shift — not incremental change, but a policy-driven transformation toward a regulated, value-based, and localized healthcare ecosystem. After reviewing recent regulatory framework…

Back to the field after the Eid break, and the energy is real! Eid was a time to recharge, reconnect, and reflect now it’s time to bring that renewed energy back to serving our healthcare partners and patients. In healthcare sales, every visit, every conversation, and every solution we provide can make a meaningf…

Saudi Pharma 2025: The End of the Riyadh-Centric Era? According to recent market intelligence and projections aligned with IQVIA insights, the Saudi pharmaceutical landscape is entering a multi-regional growth phase moving beyond its historical reliance on the Central Region. This shift is closely aligned with the…

Saudi Pharma 2026: "Strategy Will Matter More Than Scale" Following the shift toward a multi-regional market, one thing is becoming clear: Scale alone will not guarantee success anymore. For years, dominance in the Central Region was enough to drive national performance. But in the emerging landscape, winning will…

Pharmaceutical Policies in Saudi Arabia 🇸🇦 | Strategic Perspective Saudi Arabia’s pharmaceutical landscape is undergoing a structural shift — not incremental change, but a policy-driven transformation toward a regulated, value-based, and localized healthcare ecosystem. After reviewing recent regulatory framework…